At a glance
- Originator Kayaku
- Class Antineoplastics; Radiosensitisers
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Nov 1995 The chemical name for RK 28 has been added.
- 14 Nov 1995 Discontinued-Preclinical for Cancer in Japan (Unknown route)